Syngene acquires first US biologics facility for $36.5 million
Overall investment in the US facility is estimated around US$50 million
Overall investment in the US facility is estimated around US$50 million
Melicica has potential applications in skin repair, scar and acne-prone skin care, tone evening and brightening, texture improvement, baby care, sensitive skin solutions, post-procedure recovery and stretch mark care
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
This strategic partnership will also enable KIMS to exercise call option (not an obligation) to acquire majority stake in UAIMS Hospital in the coming years
ALPLA is going to manufacture high-quality plastic bottles, preforms, matching closures and injection-molded parts in Chachoengsao using all core technologies
Subscribe To Our Newsletter & Stay Updated